Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med. 2015 Jul 09; 373(2):123-35.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Female
Humans
Immunoglobulin G
Lung Neoplasms
Male
Middle Aged
Survival Analysis
Taxoids
authors with profiles
Justin Franklin Gainor, M.D.